Perioperative β-blockade to reduce cardiac morbidity in noncardiac surgery

International Anesthesiology Clinics

Volumn 39, Issue 4, 2001, Pages 93-104

  Cina, R A ^a   Froehlich, J B ^a   Hamdan, A D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

ANESTHESIA; BETA ADRENERGIC RECEPTOR BLOCKING; HEART INFARCTION; HUMAN; MORBIDITY; PEROPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SURGICAL PATIENT;

EID: 0034763491     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-200110000-00009     Document Type: Review

References (7)

1. The β-Blocker Heart Attack Trial
2. Timolol-induced reduction in mortality and reinfarction in patients surviving in acute myocardial infarction
3. Effect of beta-blockage on mortality among high-risk and low-risk patients after myocardial infarction
4. Reducing perioperative myocardial infarction following vascular surgery
5. Improvement of myocardial metabolism in coronary arterial disease by beta-blockade
6. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery
7. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery